Mid-period crossings: the quarter's story is things that started during it and are still completing
The model's full reasoning — Q2 2022 call → NO我们根据提供的财报电话会议记录,判断管理层是否描述了在报告期内或临近报告期开始的实际业务活动,并且这些活动仍在爬坡中,导致报告数字低于当前业务水平。 分析: - 管理层提到了SelectRx业务,这是一个亮点。他们表示“to date, we have completed over 40,000 gross customer enrollments, and we are beginning to hit our stride in terms of shipments and recently at list 10,000 active members receiving prescriptions.” 这表明SelectRx业务在报告期内有实际进展,从注册到发货,有实际客户接收处方。这属于实际业务活动。 - 管理层说“we remain well on pace with our original expectations of 25,000 members by the end of this fiscal year”,并计划提供更多细节。这表明该业务仍在增长中,尚未达到目标,因此报告期内的数字可能低于当前运行水平。 - 然而,这个业务是否在报告期内“开始”?从上下文看,SelectRx是在去年5月进入的,所以它可能已经运行了一段时间,但报告期内有显著增长(从11月到1月活跃会员增长75%)。但管理层没有明确说“在报告期内开始”,而是说“we have invested in the business and have significantly increased our organizational and operational capacity”,以及“we are more excited than ever about the high level of consumer interest”。这更像是业务在持续发展,而不是新开始。 - 另外,管理层主要讨论的是AEP季度的挑战,如计划同质化、关闭率下降等,这些是既有业务的波动,不是新开始的活动。 - 关于“climb incomplete”,管理层提到SelectRx会员增长,但并没有明确说报告期数字低于当前水平,只是说进展符合预期。他们提到“we exited the month of January with over 75% more active paying members than we had at the end of November”,这表明增长在加速,但并没有说报告期数字低于当前运行水平,因为报告期是截至12月31日,而1月数据是之后。 - 管理层没有明确说“因为业务在期中开始,所以报告数字只反映了部分”,而是将SelectRx作为亮点,但主要问题在于AEP的挑战。 因此,虽然SelectRx有实际活动,但管理层并没有将其描述为“在报告期内开始”的新业务,而是作为持续增长的业务。而且,管理层没有明确说报告期数字低于当前水平,因为主要讨论的是AEP的失败。 所以,答案应为NO。
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AIN | Albany International Corp. | Q3 2023 | 2023-11-07 | B |
| AFL | Aflac Incorporated | Q2 2023 | 2023-08-02 | C+ |
| CARS | Cars.com Inc. | Q1 2023 | 2023-05-06 | B |
| HLX | Helix Energy Solutions Group, Inc. | Q1 2018 | 2018-04-24 | B+ |
| SBSI | Southside Bancshares, Inc. | Q4 2017 | 2018-02-06 | A |
| ANIP | ANI Pharmaceuticals, Inc. | Q4 2016 | 2017-03-02 | B+ |
| PSX | Phillips 66 | Q4 2016 | 2017-02-03 | C+ |
| ESE | ESCO Technologies Inc. | Q2 2016 | 2016-05-03 | A |
AFL · Q2 2023 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the Japan Post cancer insurance launch in early April, which began selling the product and drove a 60% sales increase as a major contributor. They describe the activity as real and transacting, with Dan Amos noting the significant contribution from the new product. Yoshizumi confirms gradual increase going forward, and Fred highlights runway for more agents and sales calming down after initial jump, indicating the Q2 numbers reflect partial ramp-up rather than full run-rate.
ESE · Q2 2016 → YESThe question is about whether management's account of the just-reported period is built around real business activity that started partway through the period, and that the numbers average before and a...YES The transcript shows management's account centered on the real mid-period start of Plastique's contribution (acquired partway through Q2, with two months of performance noted and "early performance consistent with our acquisition forecast"), treated as a key new segment. It also explicitly addresses the incomplete climb, noting that the reported Q 2 numbers lag due to partial contribution and that Q3/Q4 will see fuller periods plus seasonality, with the business already running at a higher level as the ramp continues.
PSX · Q4 2016 → YESThe question is about whether management's account of the just-reported period is built substantially around real business activity that crossed from not-happening to happening partway through the per...YES The transcript shows management centering the Q4 story on the Freeport LPG Export Terminal's real start: commissioning completed smoothly, first commercial cargo shipped mid-December (partial Q4 contribution), with full-quarter costs incurred but only partial revenue, and explicit ramp to near-capacity loading in January onward.